Skip to main content

What the FDA labels say about taking them together

Desloratadine/pseudoephedrine and methyldopa

Desloratadine/pseudoephedrine's FDA label of November 12, 2025 names methyldopa in its drug interactions section; the methyldopa label PlainMeds reads does not name desloratadine/pseudoephedrine. The desloratadine/pseudoephedrine label: “The antihypertensive effects of beta-adrenergic blocking agents, methyldopa, and reserpine, may be reduced by sympathomimetics such as pseudoephedrine.”

Check it at the source: the desloratadine/pseudoephedrine FDA label on DailyMed (effective November 12, 2025); the methyldopa FDA label on DailyMed (effective March 26, 2025, Chartwell RX, LLC).

What does the desloratadine/pseudoephedrine label say about methyldopa?

Desloratadine/pseudoephedrine label, drug interactions

The antihypertensive effects of beta-adrenergic blocking agents, methyldopa, and reserpine, may be reduced by sympathomimetics such as pseudoephedrine.

Source: FDA drug label (CLARINEX-D 12 HOUR), Organon LLC, effective November 12, 2025 (SPL set 1af66b7a-4ab8-40d8-abdd-22d3310228a8), via openFDA; the full label on DailyMed

What does the methyldopa label say about desloratadine/pseudoephedrine?

Methyldopa's label (effective March 26, 2025) does not name desloratadine/pseudoephedrine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Methyldopa), Chartwell RX, LLC, effective March 26, 2025 (SPL set e1114a58-9ab5-486e-85ed-360365b06396), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Desloratadine/pseudoephedrine generic labelers
1Methyldopa generic labelers
Desloratadine/pseudoephedrineMethyldopa
Labeled forAllergiesn/a
Boxed warningNoNo
Pharmacy cost (NADAC)$6.07 per tablet 12 hr 2.5-120 mg tabletn/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?